Former Hockey News Senior Writer Gets A New Lease On Life
Mike Brophy, who was THN's senior writer for 17 years, received a kidney donation on Thursday at the Ottawa Civic Hospital. If you remember a video I did a couple of months ago appealing for a donor, you'll know that it was indeed a life-saving procedure. Simply put, 'Broph' would not have been with us much longer if not for the generosity and selflessness of his former sister-in-law.
Broph wants everyone in the hockey world to know how grateful he is for the outpouring of support and encouragement he received throughout this process. And now he can get on with watching his grandchildren grow up. A good day all around.
To ensure more people like Broph get a new lease on life, consider being a living kidney donor. If you're in the Ottawa area and are interested in being screened as a potential donor can, go to www.tohlivingkidneydonation.com or call the Ottawa Hospital at (613) 738-8400, ext. 82719.
If you reside in Canada and want to learn more about being a kidney donor, visit kidney.ca and blood.ca. If you reside in the United States, visit kidneyregistry.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
5 Supplements That Don't Mix Well with Coffee, According to Pharmacists
Reviewed by Dietitian Maria Laura Haddad-GarciaKey Points Coffee may reduce the absorption of iron, calcium, magnesium and some vitamins. Wait at least 1 hour after coffee to take supplements for better nutrient uptake. Not everyone needs supplements—talk to your provider before adding them to your you're the kind of person who can't start their day without a cup (or two) of coffee, you're not alone. Coffee is a staple morning ritual—whether it's sipped alongside breakfast, before a workout or first thing after waking up, that morning brew helps us feel energized and ready for the day. But if you also take vitamins or minerals as part of your morning routine, it's worth knowing how coffee might influence how your body absorbs those nutrients. Caffeine, polyphenols and coffee's mild diuretic effect can interfere with how your body uses certain vitamins and minerals. "For instance, iron absorption can be slowed by caffeine and caffeine can impact certain nutrients via its diuretic properties," says Philip Ngo, Pharm.D. We spoke with pharmacists to understand how coffee can impact nutrient absorption—and what you can do to get the most from your supplements. 1. Iron Iron is essential for growth, hormone production and cellular function. And it's a common nutrient deficiency, so your healthcare provider may have suggested supplementing. "Having coffee with an iron supplement or fortified cereal may make your body absorb less iron," notes Bo Wang, M.D., Pharm.D. "Over time, a heavy caffeine habit could potentially impact bone and mineral health." One study found that drinking coffee with iron reduced absorption by 54%. Pairing it with breakfast further lowered absorption. This interaction isn't about the caffeine—it's due to chlorogenic acid, a polyphenol in coffee and tea. "This compound is a strong inhibitor of non-heme iron absorption (the type found in plant foods and supplements)," adds Elise Kim, Pharm.D., BCACP, CDCES, AHSCP-CHC. Researchers believe that the polyphenols may impact the way our gut absorbs iron. Wang recommends separating iron from coffee by at least one hour and pairing it with vitamin C-rich foods, such as lemons and oranges, to enhance absorption. 2. Vitamin D Vitamin D is a nutrient that is hard to get through diet alone, since it's not naturally found in many foods. However, our bodies can also make vitamin D from sunshine. "Research suggests that caffeine may reduce the expression of vitamin D receptors, which can lower vitamin D levels," says Kim. "However, its clinical impact is still being studied." A 2021 study linked higher caffeine intake with lower circulating levels of vitamin D, though more research is needed. To get the most from your supplement, consider spacing it at least an hour away from your coffee, Ngo suggests. And since vitamin D is fat-soluble, taking it with a meal that includes healthy fats can help improve absorption. 3. B Vitamins This group of water-soluble vitamins—including B1, B2, B7, B9 and B12—supports energy production, nerve function and red blood cell formation. Water-soluble vitamins dissolve in water, and our bodies cannot store a lot of excess at one time. "As B vitamins are water-soluble, caffeine's mild diuretic effect can increase how much your body excretes, especially with higher caffeine intake," says Kim. Studies show that people who drink coffee tend to have lower levels of circulating B vitamins, likely due to urinary losses. 'Avoid taking supplements with coffee or tea," advises Wang. "Wait an hour if you can. Water-soluble vitamins (C, Bs) are fine with or without food, but may go down easier after a meal." 4. Magnesium Magnesium is an important mineral that plays a role in protein synthesis, blood sugar management, blood pressure regulation and sleep quality. While it's found in foods like beans, nuts and yogurt, many people don't get enough from diet alone. "Caffeine can increase calcium and magnesium loss through urine," notes Kim. If you're taking magnesium as part of a nighttime routine—a common supplement to help you sleep better—it's best to avoid caffeine close to bedtime. Not only can caffeine interfere with sleep, but it may also reduce magnesium's effectiveness in promoting deeper rest. 5. Calcium Just like magnesium, calcium may be impacted by coffee's diuretic effects. "Calcium absorption may be reduced by caffeine, but the clinical impact remains unclear," says Kim. A study showed that participants who consumed caffeine had 77% more calcium excreted by their kidneys compared to a placebo group. Adding milk to your coffee may help offset calcium loss, and spacing out calcium supplements at least one hour after your coffee—or two hours before—can help support better absorption, suggests Kim. Our Expert Take Coffee can influence how your body absorbs certain nutrients, but simple timing tweaks can help. Spacing out your supplements from coffee by an hour can support better absorption. If you occasionally forget and take them together, you'll still likely absorb some nutrients. And in spite of what you may see being pushed by wellness influencers, not everyone needs supplements. "Supplements are just that—to supplement," says Ngo. "For a person in good general health who consumes a balanced diet, it may not be worth investing in supplements unless you are truly deficient." Chatting with a health care provider and lab testing can help determine what's best for you. Read the original article on EATINGWELL
Yahoo
an hour ago
- Yahoo
Addus HomeCare (ADUS) Q2 Earnings: What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday afternoon. Here's what you need to know. Addus HomeCare missed analysts' revenue expectations by 0.6% last quarter, reporting revenues of $337.7 million, up 20.3% year on year. It was a mixed quarter for the company, with a narrow beat of analysts' sales volume estimates. Is Addus HomeCare a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Addus HomeCare's revenue to grow 20.8% year on year to $346.5 million, improving from the 10.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.46 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Addus HomeCare has missed Wall Street's revenue estimates three times over the last two years. Looking at Addus HomeCare's peers in the senior health, home health & hospice segment, some have already reported their Q2 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 15.3%, beating analysts' expectations by 5.2%, and Option Care Health reported revenues up 15.4%, topping estimates by 4.6%. Option Care Health traded down 2.7% following the results. Read our full analysis of BrightSpring Health Services's results here and Option Care Health's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the senior health, home health & hospice stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Addus HomeCare is down 5.3% during the same time and is heading into earnings with an average analyst price target of $136.45 (compared to the current share price of $104.74). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
What To Expect From Hims & Hers Health's (HIMS) Q2 Earnings
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after market hours. Here's what to expect. Hims & Hers Health beat analysts' revenue expectations by 8.3% last quarter, reporting revenues of $586 million, up 111% year on year. It was a strong quarter for the company, with a solid beat of analysts' EPS estimates and full-year EBITDA guidance beating analysts' expectations. It added 137,000 customers to reach a total of 2.37 million. Is Hims & Hers Health a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Hims & Hers Health's revenue to grow 74.5% year on year to $550.8 million, improving from the 51.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.23 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Hims & Hers Health has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 3.2% on average. Looking at Hims & Hers Health's peers in the healthcare technology segment, only Omnicell has reported results so far. It beat analysts' revenue estimates by 4.9%, delivering year-on-year sales growth of 5%. The stock price was unchanged following the results. Read our full analysis of Omnicell's earnings results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the healthcare technology stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Hims & Hers Health is up 29% during the same time and is heading into earnings with an average analyst price target of $48.36 (compared to the current share price of $62.48). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
